about
negative regulation of acute inflammatory responsenegative regulation of respiratory burst involved in inflammatory responsenegative regulation of chronic inflammatory responsenegative regulation of cytokine production involved in inflammatory responsenegative regulation of inflammatory response to antigenic stimulusnegative regulation by organism of inflammatory response of other organism involved in symbiotic interactionnegative regulation of histamine secretion by mast cellnegative regulation of leukotriene production involved in inflammatory responsenegative regulation of inflammatory response to woundingnegative regulation of neuroinflammatory response
P279
Nuclear receptor subfamily 1 group H member 4MEFV innate immuity regulator, pyrinApolipoprotein A1Adiponectin, C1Q and collagen domain containingGhrelinKeratin 1Interleukin 10Interleukin 2Adenosine deaminasePROCProtein CForkhead box P3Mediterranean feverAdenosine A1 receptorSMAD family member 3Nuclear receptor subfamily 1, group H, member 4NLR family, pyrin domain containing 3Hepatocyte growth factorInterleukin 22Acid phosphatase 5, tartrate resistantApolipoprotein A-IProstaglandin I2 (prostacyclin) synthaseMevalonate kinaseGrowth hormone secretagogue receptorNuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105Nuclear receptor subfamily 1 group D member 1RAR-related orphan receptor alphaNuclear receptor subfamily 1, group D, member 2Superoxide dismutase 1, solubleSuperoxide dismutase 1TEK receptor tyrosine kinaseGATA binding protein 3Sphingomyelin phosphodiesterase acid like 3BASH1 like histone lysine methyltransferaseInterleukin 22 receptor subunit alpha 2Meteorin like, glial cell differentiation regulatorFibronectin type III domain containing 4Formyl peptide receptor 2Forkhead box F1TNF alpha induced protein 3
P682
Effect of serum amyloid A on selected in vitro functions of isolated human neutrophilsThe orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory responseThe role of the novel adipocyte-derived hormone adiponectin in human diseaseGhrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cellsProtection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cellsClinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutationsA novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signalingHuman multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonismMutations in NALP12 cause hereditary periodic fever syndromesActivation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cellsAcid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipidHeterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypesCellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activationPhenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutationsThe Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer CellsAA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two casesPro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationNeuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEMMicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin.The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation
P921
Q14758902-65314E6E-07D3-4338-BCFE-287757C1E146Q14761973-B69F69E0-B413-4765-BE0A-979474028D90Q14865617-C52386E3-BDD1-4D60-9E26-FF06B98A4F1CQ14910955-03D8698D-0564-4017-82C8-A4B0BA34F904Q14912566-6826BDB7-F393-4708-9390-03D0C3B402CBQ22273953-42337501-808E-463D-8ABF-D6019C01F0B7Q22302411-5C290820-F734-4671-A0E9-A293ED0C6BD9Q22302413-5C2A326D-0D5B-4330-9577-0FACC455B50EQ29877221-AF22D8F9-C1F8-42F0-B90D-8ABBBEFB5D2AQ56058244-827416ED-A530-4712-BEEE-7D48D6871C3C
P279
Q1085078-DA45F3F9-BB27-4FCA-8D6A-62662F99789DQ1085078-F8EBD1A1-B861-4DD1-891F-5FC58E3B9488Q11681842-582C512D-9535-493A-9C61-36098D2708F6Q1316030-425BDA07-6EB3-4EF0-8F12-A9926791B10AQ14864062-42BED046-B50E-4179-932A-0FB367DE0792Q14864125-B6D3C5DE-9DF6-4CDD-94F0-925A222FE680Q14864150-A6A5608C-D7C7-44FE-BF96-6F8EEB58B663Q14864467-77D07123-1FE0-4189-AE05-9E48CDA262D7Q14864467-CD464DCE-8158-4E1B-927C-104B1164A758Q14864519-100EB5D4-5FC6-4E7C-B7F1-AB082CDA7B87Q14864795-DA3014D4-CCB2-4B88-9311-B700C657E195Q14864945-6718CB92-EC16-4D94-9F87-C99533CB63F2Q14864947-35EB4C02-54B9-4616-B984-BC7D7A9DBD36Q14864947-847DF119-D0DA-453B-ABCC-CE9A32F4E3A3Q14865673-55AB46A6-0D37-435A-AFFE-72C2EA3421ACQ14881891-9A16E9EC-1C2B-44B2-B64F-91E9A0F2454DQ14888630-D67AD4A5-6E30-46F8-BE2B-1EA1724186C7Q14903978-67CC13BF-3AD0-4DB3-86A9-31A5CC353B89Q14905046-2571AD22-ED56-44B1-BB89-908D3B38A905Q14905046-8A433F9F-D058-4026-B37C-197AFE56E38DQ14905621-79D763C2-A90D-4671-9E2C-9430FCE54F48Q14906215-CE67FD74-72AF-4C46-8301-B5E85FE2D252Q14907280-7BAC6B1F-3FD1-4481-BB18-83EBE3EA0589Q14907833-A3A3DFC6-0C1F-4588-9255-13CCDD485C8CQ14910072-6991E588-B2D7-4486-8A6B-27FF413E40B0Q14911843-4B00B639-6C03-4E25-9FE8-BF8ADBB00871Q14913013-9F9EB1C4-0243-495C-B214-9AE5562ACF74Q14914303-BE6EE40C-F343-4BED-96FF-7C8773DD24AEQ15317485-2BC8E1AD-25AD-4501-801F-795A01D700B6Q15323346-E001409D-AB90-48B1-B49F-44C7D3FF2AD5Q15326513-9F0E0989-78B2-4C6F-8D22-94048316F631Q15326513-DD3B60D6-F7A2-4355-9B9E-BC381649C5E8Q15327805-8AEFC62D-E4CE-411F-9ADC-9C8CF3B07113Q15328173-4C130A20-87F9-44C3-AF2E-87C16D379357Q2041084-B0E03055-516D-4BF1-AAFB-DC1A925176CBQ21097266-C282B93B-1201-4362-A28B-8261501C464AQ21101536-4FE02330-645A-4D48-BAC6-DA95C1E16AC7Q21102089-5A4FD68C-EF16-4608-BBA6-C58323F7E8A1Q21102102-B6B73F43-4E7E-4198-AE58-9FFFBF38C29DQ21103404-5DFE03F8-56F7-4572-B70A-452C3DB5E632
P682
Q22008031-E0BF549B-234B-4EF2-A1E6-5CB78800CA30Q24290927-C75EB394-B2F9-46DA-9B41-04D7FC62B6D6Q24296429-5C154A2A-09CF-45E1-8E89-C0593255BC56Q24298483-E5FD0A04-43D0-4F79-A72C-888EF4879B71Q24299562-BFCCDB6F-EE9A-4317-A08F-196265BF5B54Q24300638-0EBD86FE-173A-4E02-ADFB-4E6B24EC7D07Q24301534-14E95553-3B26-45F9-BA52-BCA1A5B06BC1Q24302245-61989EBC-9641-4ACA-BE81-BFA07F589C11Q24307718-3C3353C7-D302-4A4C-8A7D-D8F806293A0DQ24308730-C156E36A-44D8-45CA-A51C-6792095442D0Q24312093-AF4356A2-7E46-4CDB-827F-2215FBDA6EE5Q24320202-957E17ED-21B6-4AA8-92C4-D6269E0FF538Q24329184-5CE76382-F407-4154-BDC6-079CC732FE3EQ24337324-775F9C48-A566-47CD-A93B-23DB58AE3E5BQ24337484-7D90B32F-11F1-4F6F-9D00-9522F8C9B047Q24338163-5661A45B-34C7-4AB9-AB39-7D7B0800630CQ24338312-F0C46973-F131-4C3B-AF24-2B8FD89D67D8Q34157528-B2F22381-C9C9-49C1-A1D7-10813765A71CQ36839780-0D49B6DF-6F87-4596-8835-0A2EA2FA2B5FQ47073092-291F3D6D-077A-4753-8FA7-13F386C0A4FEQ91117079-28A914B5-DEBC-4812-80E2-20F746D0B429
P921
description
Any process that stops, preven ...... of the inflammatory response.
@en
biologisch proces
@nl
name
negative regulation of inflammatory response
@en
type
label
negative regulation of inflammatory response
@en
altLabel
GO:0050728
@en
anti-inflammatory response
@en
down regulation of inflammatory response
@en
down-regulation of inflammatory response
@en
downregulation of inflammatory response
@en
prefLabel
negative regulation of inflammatory response
@en
P279
P279
P2888
P686
GO:0050728